Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
doi:10.1056/NEJMoa1411892
Liraglutide had a similar effect but to a slightly lesser extent, which the authors attribute to differences in doses and treatment approach of the two drugs
JAMAs Post JAMA 222,534 followers Report this post Use of GLP-1 agonists for weight loss, compared with use of bupropion-naltrexone, was associated with an increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease
#NICE #NHS #Generics #Biosimilars To view or add a comment, sign in Huge thanks to Dominic Wake and Jacoline Bouvy for their participation in our latest podcast episode
View Study Yu L, Li L
US$ 24.09
US$ 24.92
US$ 29.41
US$ 25.20
US$ 22.55
US$ 22.67
